Escitalopram and Depression in Elderly Alzheimer's Patients

University of British Columbia

Status and phase: Terminated; Phase 3

Conditions: Depressive Disorder

Treatments: Drug: Escitalopram

Study type: Interventional

Funder types: Other

Identifiers

NCT00488670

H07-00050

Details and patient eligibility

About

To investigate the effect of Escitalopram in a large and diverse of dementia patients suffering from depression.

Full description

This study will assess the efficacy, tolerability, and safety of escitalopram in the treatment of Major Depressive Disorder in patients with Alzheimer's disease over a 24-week period. It will also assess the efficacy and tolerability of escitalopram after 12 weeks of treatment.

Enrollment: 50 estimated patients

Sex: All

Ages: 50+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

• > 50 years
• Male & female
• Alzheimer's disease
• Depressive episode

Trial design

Primary purpose: Treatment

Allocation: Non-Randomized

Interventional model: Single Group Assignment

Masking: None (Open label)